Michelle S Keller
Overview
Explore the profile of Michelle S Keller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
305
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tantipinichwong N, Keller M
Sci Rep
. 2024 Dec;
14(1):31719.
PMID: 39738189
The unintended consequences of polypharmacy pose significant risks to older adults. The complexities of managing numerous medications from multiple prescribers demand a comprehensive approach to mitigate harms. Pharmacist-led clinics have...
2.
Keller M, Guevara N, Guerrero J, Mays A, McCleskey S, Reyes C, et al.
BMC Geriatr
. 2024 Aug;
24(1):725.
PMID: 39217285
Background: Latinos are more likely than non-Latino Whites to develop dementia and be prescribed antipsychotics for dementia-related behavioral symptoms. Antipsychotics have significant risks yet are often overprescribed. Our understanding of...
3.
Essien U, Keller M
JAMA Intern Med
. 2024 Aug;
184(10):1258-1259.
PMID: 39133477
No abstract available.
4.
Oche O, Murry L, Keller M, Pevnick J, Schnipper J, Nguyen A, et al.
Res Social Adm Pharm
. 2024 May;
20(8):740-746.
PMID: 38744561
Background: The PHARMacist Discharge Care (PHARM-DC) intervention is a pharmacist-led Transitions of Care (TOC) program intended to reduce 30-day hospital readmissions and emergency department visits which has been implemented at...
5.
Ge Y, Xu S, Capron A, Keller M, Hlavka J
J Appl Gerontol
. 2024 May;
43(11):1640-1656.
PMID: 38742826
In this study, we employed a pre-interview survey and conducted interviews with nursing home staff members and residents/family members to understand their perceptions of whether the COVID-19 restrictions fulfilled obligations...
6.
Le T, Campbell S, Andraos A, Ahlmark P, Hoang H, Isserman S, et al.
BMJ Open
. 2024 Apr;
14(4):e080109.
PMID: 38569687
Objectives: Long-term benzodiazepine use is common despite known risks. In the original Eliminating Medications Through Patient Ownership of End Results (EMPOWER) Study set in Canada, patient education led to increased...
7.
Keller M, Qureshi N, Mays A, Sarkisian C, Pevnick J
JAMA Netw Open
. 2024 Jan;
7(1):e2350963.
PMID: 38198136
Importance: Polypharmacy is associated with mortality, falls, hospitalizations, and functional and cognitive decline. The study of polypharmacy-related interventions has increased substantially, prompting the need for an updated, more focused systematic...
8.
Silva Almodovar A, Keller M, Lee J, Mehta H, Manja V, Pham Nguyen T, et al.
J Am Geriatr Soc
. 2023 Nov;
72(3):660-669.
PMID: 37943070
Deprescribing is the intentional dose reduction or discontinuation of a medication. The development of deprescribing interventions should take into consideration important organizational, interprofessional, and patient-specific barriers that can be further...
9.
Keller M, Sarkisian C
Ann Intern Med
. 2023 Oct;
176(11):1548-1549.
PMID: 37871319
No abstract available.
10.
Qureshi N, Keller M
J Gen Intern Med
. 2023 Aug;
38(15):3381-3388.
PMID: 37620719
Background: Pharmacist-led programs and clinics have been integrated into primary and specialty care clinics in a variety of ways, for example, to improve diabetes outcomes via patient education and counseling....